Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Zineh

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Pharmacogenomics|December 15, 2010
Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomicsPeter M Shaw, Issam Zineh
Annals of Internal Medicine|August 2, 2016
The Biosimilarity Concept: Toward an Integrated Framework for Evidence AssessmentIssam Zineh, Leah A Christl
Expert Opinion on Pharmacotherapy|July 25, 2006
Pharmacogenetics of chronic cardiovascular drugs: applications and implicationsIssam Zineh, Julie A Johnson
Personalized Medicine|May 23, 2018
Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogueIssam Zineh, Lawrence J Lesko
Pharmacotherapy|September 20, 2011
Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug AdministrationIssam Zineh, Michael A Pacanowski
Pharmacogenomics|March 31, 2010
DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDALawrence J Lesko, Issam Zineh
The New England Journal of Medicine|December 17, 2013
Pharmacogenetics and coumarin dosing--recalibrating expectationsIssam Zineh, Michael Pacanowski, Janet Woodcock
CPT: Pharmacometrics & Systems Pharmacology|December 25, 2018
A Holistic and Integrative Approach for Advancing Model-Informed Drug DevelopmentRajanikanth Madabushi, Yaning Wang, Issam Zineh
JAMA|May 10, 2012
New genetic discoveries and treatment for hepatitis CMichael Pacanowski, Shashi Amur, Issam Zineh
Clinical Pharmacology and Therapeutics|November 21, 2017
Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United StatesMichele K Dougherty, Issam Zineh, Leah Christl
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Pharmacogenomics|December 15, 2010
Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomicsPeter M Shaw, Issam Zineh
Annals of Internal Medicine|August 2, 2016
The Biosimilarity Concept: Toward an Integrated Framework for Evidence AssessmentIssam Zineh, Leah A Christl
Expert Opinion on Pharmacotherapy|July 25, 2006
Pharmacogenetics of chronic cardiovascular drugs: applications and implicationsIssam Zineh, Julie A Johnson
Personalized Medicine|May 23, 2018
Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogueIssam Zineh, Lawrence J Lesko
Pharmacotherapy|September 20, 2011
Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug AdministrationIssam Zineh, Michael A Pacanowski
Pharmacogenomics|March 31, 2010
DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDALawrence J Lesko, Issam Zineh
The New England Journal of Medicine|December 17, 2013
Pharmacogenetics and coumarin dosing--recalibrating expectationsIssam Zineh, Michael Pacanowski, Janet Woodcock
CPT: Pharmacometrics & Systems Pharmacology|December 25, 2018
A Holistic and Integrative Approach for Advancing Model-Informed Drug DevelopmentRajanikanth Madabushi, Yaning Wang, Issam Zineh
JAMA|May 10, 2012
New genetic discoveries and treatment for hepatitis CMichael Pacanowski, Shashi Amur, Issam Zineh
Clinical Pharmacology and Therapeutics|November 21, 2017
Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United StatesMichele K Dougherty, Issam Zineh, Leah Christl
Pageof 13